Published in Front Physiol on June 28, 2012
The role of engineering approaches in analysing cancer invasion and metastasis. Nat Rev Cancer (2013) 0.86
Contribution of bioinformatics prediction in microRNA-based cancer therapeutics. Adv Drug Deliv Rev (2014) 0.76
Advances in systems immunology and cancer. Front Physiol (2014) 0.75
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
On the origin of cancer cells. Science (1956) 49.55
KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res (1999) 40.62
A census of human cancer genes. Nat Rev Cancer (2004) 36.20
Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Sparse inverse covariance estimation with the graphical lasso. Biostatistics (2007) 24.38
WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics (2008) 18.58
Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res (2008) 15.69
The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science (2002) 13.86
Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics (2000) 13.33
Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A (2007) 11.46
Computational systems biology. Nature (2002) 10.33
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res (2009) 9.59
Apoptosis: a link between cancer genetics and chemotherapy. Cell (2002) 7.86
Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res (2003) 7.22
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33
Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov (2011) 5.79
Applications of genome-scale metabolic reconstructions. Mol Syst Biol (2009) 5.54
Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science (2005) 5.14
Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science (2005) 4.83
Oscillations and variability in the p53 system. Mol Syst Biol (2006) 4.59
The road to modularity. Nat Rev Genet (2007) 4.34
Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol (2006) 4.30
From signatures to models: understanding cancer using microarrays. Nat Genet (2005) 4.29
High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics. J Am Stat Assoc (2008) 3.92
Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol (2011) 3.65
Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics (2001) 3.16
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res (2005) 3.10
Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res (2005) 2.63
Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol Syst Biol (2010) 2.60
Metabolic flux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions. BMC Bioinformatics (2000) 2.50
Reconstructing gene regulatory networks with bayesian networks by combining expression data with multiple sources of prior knowledge. Stat Appl Genet Mol Biol (2007) 2.47
Logic-based models for the analysis of cell signaling networks. Biochemistry (2010) 2.21
Flux balance analysis in the era of metabolomics. Brief Bioinform (2006) 2.14
Sloppy models, parameter uncertainty, and the role of experimental design. Mol Biosyst (2010) 2.12
Reverse engineering the genotype-phenotype map with natural genetic variation. Nature (2008) 2.06
Predictive biomarkers: a paradigm shift towards personalized cancer medicine. Nat Rev Clin Oncol (2011) 2.02
Clustering cancer gene expression data: a comparative study. BMC Bioinformatics (2008) 2.00
Network inference using informative priors. Proc Natl Acad Sci U S A (2008) 1.96
Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics (2006) 1.95
Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci (1983) 1.85
Understanding NF-kappaB signaling via mathematical modeling. Mol Syst Biol (2008) 1.79
Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochem J (2005) 1.70
Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg effect. PLoS Comput Biol (2011) 1.66
Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res (1953) 1.64
Synthetic lethal screen of an EGFR-centered network to improve targeted therapies. Sci Signal (2010) 1.64
CAUSAL GRAPHICAL MODELS IN SYSTEMS GENETICS: A UNIFIED FRAMEWORK FOR JOINT INFERENCE OF CAUSAL NETWORK AND GENETIC ARCHITECTURE FOR CORRELATED PHENOTYPES. Ann Appl Stat (2010) 1.62
Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet (2007) 1.55
Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol (1984) 1.51
Cell signaling and cancer. Cancer Cell (2003) 1.50
Cancer metabolism: is glutamine sweeter than glucose? Cancer Cell (2010) 1.41
Quantifying cancer progression with conjunctive Bayesian networks. Bioinformatics (2009) 1.37
Science funding: Provocative questions in cancer research. Nature (2012) 1.36
Practical limits for reverse engineering of dynamical systems: a statistical analysis of sensitivity and parameter inferability in systems biology models. Mol Biosyst (2011) 1.35
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. J Am Med Assoc (1946) 1.33
Mathematical modeling of cancer progression and response to chemotherapy. Expert Rev Anticancer Ther (2006) 1.30
A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents. J Theor Biol (2006) 1.17
Combining microarrays and biological knowledge for estimating gene networks via bayesian networks. J Bioinform Comput Biol (2004) 1.16
Critical reasoning on causal inference in genome-wide linkage and association studies. Trends Genet (2010) 1.15
Biology-driven cancer drug development: back to the future. BMC Biol (2010) 1.12
Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility. Genome Biol (2011) 1.08
Defining gene and QTL networks. Curr Opin Plant Biol (2009) 1.00
A Bayesian framework for inference of the genotype-phenotype map for segregating populations. Genetics (2011) 0.99
Macroscopic law of conservation revealed in the population dynamics of Toll-like receptor signaling. Cell Commun Signal (2011) 0.99
A comparison of non-standard solvers for ODEs describing cellular reactions in the heart. Comput Methods Biomech Biomed Engin (2007) 0.97
Genome-scale modeling and in silico analysis of mouse cell metabolic network. Mol Biosyst (2009) 0.95
Enhancing apoptosis in TRAIL-resistant cancer cells using fundamental response rules. Sci Rep (2011) 0.94
Data integration for dynamic and sustainable systems biology resources: challenges and lessons learned. Chem Biodivers (2010) 0.94
Preliminary investigation of a Bayesian network for mammographic diagnosis of breast cancer. Proc Annu Symp Comput Appl Med Care (1995) 0.92
Drug development: portals of discovery. Clin Cancer Res (2012) 0.90
Selecting high-dimensional mixed graphical models using minimal AIC or BIC forests. BMC Bioinformatics (2010) 0.89
Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling. Toxicol Appl Pharmacol (1990) 0.85
A Bayesian network for diagnosis of primary bone tumors. J Digit Imaging (2001) 0.82
Targeted therapy in the treatment of solid tumors: practice contradicts theory. Biochemistry (Mosc) (2008) 0.81
Effects of genetic and environmental factors on trait network predictions from quantitative trait locus data. Genetics (2009) 0.81
Bayesian Learning in Sparse Graphical Factor Models via Variational Mean-Field Annealing. J Mach Learn Res (2010) 0.78